{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:58:54Z","timestamp":1790200734981,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5,27]]},"DOI":"10.1097\/01.tp.0000158021.66004.19","type":"journal-article","created":{"date-parts":[[2005,5,17]],"date-time":"2005-05-17T04:01:18Z","timestamp":1116302478000},"page":"1422-1427","source":"Crossref","is-referenced-by-count":14,"title":["Resistance to Activated Protein C Caused by Factor V Leiden Mutation and Orthotopic Liver Transplantation"],"prefix":"10.1097","volume":"79","author":[{"given":"Andreas","family":"Loew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3","key":"R1-27-20210129","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.","volume":"90","author":"Dahlback","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R2-27-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C.","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"R3-27-20210129","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease.","volume":"353","author":"Rosendaal","year":"1999","journal-title":"Lancet"},{"issue":"11","key":"R4-27-20210129","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1182\/blood.V88.11.4398.4398","article-title":"High sensitivity and specificity of a coagulant essay for the detection of heterozygous and homozygous factor V Leiden-based resistance to activated protein C.","volume":"88","author":"Riewald","year":"1996","journal-title":"Blood"},{"key":"R5-27-20210129","first-page":"113","article-title":"Inactivation of accelerin determines resistance to activated protein C.","volume":"41","author":"Hintz","year":"1995","journal-title":"Clin Lab"},{"key":"R6-27-20210129","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1055\/s-0038-1655964","article-title":"Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.","volume":"77","author":"Svensson","year":"1997","journal-title":"Thromb Haemost"},{"issue":"1","key":"R7-27-20210129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00001721-199601000-00008","article-title":"Phenotypic correction of activated protein C resistance following orthotopic liver transplantation.","volume":"7","author":"Foster","year":"1996","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"R8-27-20210129","first-page":"111","article-title":"Factor V Leiden in absence of activated protein C resistance after orthotopic liver transplantation in a patient without thrombosis but with familial thrombophilia.","volume":"85","author":"Estell\u00e9s","year":"2000","journal-title":"Haematologica"},{"issue":"4","key":"R9-27-20210129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00001721-199906000-00008","article-title":"Is activated protein C resistance following orthotopic liver transplantation a risk factor for venous Thrombosis?","volume":"10","author":"De Mitrio","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"8","key":"R10-27-20210129","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1182\/blood.V97.8.2525","article-title":"Discrepancy between phenotype and genotype on screening for factor V Leiden after transplantation.","volume":"97","author":"Parker","year":"2001","journal-title":"Blood"},{"issue":"25","key":"R11-27-20210129","first-page":"783","article-title":"Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population.","volume":"124","author":"Ehrenforth","year":"1999","journal-title":"Dtsch Med Wochenschr"},{"key":"R12-27-20210129","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.1997.03540400055031","article-title":"Ethnic distribution of factor V Leiden in 4047 men and women: implications for venous thromboembolism screening.","volume":"277","author":"Ridker","year":"1997","journal-title":"JAMA"},{"issue":"4","key":"R13-27-20210129","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1365-2141.2001.03203.x","article-title":"The phenomenon known as acquired activated protein C resistance.","volume":"115","author":"Clark","year":"2001","journal-title":"Br J Haematol"},{"issue":"6","key":"R14-27-20210129","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/gut.40.6.798","article-title":"Prevalence of the factor V Leiden mutation and portal vein thrombosis.","volume":"40","author":"Mahmoud","year":"1997","journal-title":"Gut"},{"issue":"7","key":"R15-27-20210129","first-page":"2364","article-title":"Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.","volume":"96","author":"Janssen","year":"1","journal-title":"Blood"},{"issue":"1","key":"R16-27-20210129","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/lt.500040108","article-title":"Donor factor V Leiden mutation and vascular thrombosis following liver transplantation.","volume":"4","author":"Hirshfield","year":"1998","journal-title":"Liver Transpl Surg"},{"issue":"3","key":"R17-27-20210129","first-page":"525","article-title":"Recurrent venous thrombosis despite correction of activated Protein C resistance following orthotopic liver transplantation.","volume":"80","author":"Biesma","year":"1998","journal-title":"Thromb Haemost"},{"issue":"9","key":"R18-27-20210129","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood.V92.9.3035","article-title":"Secretable human platelet-derived factor V originates from the plasma pool.","volume":"92","author":"Camire","year":"1","journal-title":"Blood"},{"issue":"1","key":"R19-27-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-0038-1642667","article-title":"New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by ArG 506 to Gln Mutation in FV as a pathogenetic risk factor for venous thrombosis.","volume":"74","author":"Dahlb\u00e4ck","year":"1995","journal-title":"Thromb Haemost"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.TP.0000158021.66004.19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:30:39Z","timestamp":1785853839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200505270-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,27]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000158021.66004.19","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5,27]]}}}